Texas Tech University Health Sciences Center’s Post

Congratulations to Gene Ray, Mark S. Walker, Claudio D’Ambrosio, and the co-authors on the publication of their manuscript "Comparing prospectively assigned trial and real-world lung cancer patients" in the Journal of Comparative Effectiveness Research! This study evaluated the comparability of a clinical trial cohort with a real-world cohort using electronic medical records data. The results suggest that survival patterns between these two groups in the NSCLC setting are not statistically significantly different. Read more: https://hubs.ly/Q02DjR_v0 #lungcancer #research #medicaldata #congratulations #ComparativeEffectivenessResearch

Which viruses change proteins, ultimately accelerating the development of cancer? Why does this happen only in certain cases, and how can it be stopped? Find answers at Prof. Meir Shamay's laboratory - Viral Oncology and Epigenetics. Prof. Shamay teaches in our medical sciences graduate degree programs. Learn more here https://lnkd.in/d-mvTg3G Bar-Ilan University

📢Happy to share the Special Issue "Exploiting Metabolic Weaknesses: A Novel Approach to Overcome Drug Resistance in Cancer Therapy" 💝Edited by Medhi Wangpaichitr from Miller School of Medicine, University of Miami Journal of Personalized Medicine MDPI 📅Welcomes your submissions； Deadline for manuscript submissions: 25 January 2025 🛩️https://lnkd.in/gzrkXE2e #tumor metabolism; #metabolomics; #metabolites

https://lnkd.in/eDdKH8Yh Join Dr. Eduardo Beltran, a Integrative Functional Physician, research scientist and vitamin D expert, as he engages in a profound discussion with renowned researcher Dr. Thomas Seyfried, a pioneer in cancer biology. This interview delves into Seyfried’s groundbreaking theory that cancer is not primarily a genetic disease but a metabolic disorder linked to mitochondrial dysfunction. By examining energy metabolism in cancer cells, Dr. Seyfried challenges traditional approaches, advocating for treatments targeting metabolic pathways. The discussion also emphasizes the shortcomings in current medical education and calls for a reform to include this critical understanding of cancer biology. Dr. Seyfried's research has shown promising results, helping patients achieve remission, offering a new avenue for cancer therapies, and revolutionizing our approach to cancer care. Learn how these cutting-edge discoveries could reshape the future of cancer treatment and medical education. Links for the Book: Cancer as a Metabolic Disease: https://a.co/d/e8ph7s9 Published Papers: https://nutritionandmetabolism.biomed...

New from JN Learning: USPSTF Report: Collaborative Modeling to Compare Breast Cancer Screening Strategies https://lnkd.in/geh8pget

Raman Spectroscopy in the Field of Cancer Diagnostics

SiriSree's New Clear Medicine NMMI Service 18F FDG PET CT MiTNM Scitigraphy Oral Cavity Cancer Clinical Biograph: Evolutionary, Abiotic, Prebiotic, Biotic, Phylogenetic, Ontogenetic Oncogeny ·TNM Staging: Deterministic Signature Lifecycle of Stochastic Cancer ·Clinical Indications and Scenarios: Imaging Appropriate Use Criteria ACR Appropriate Use Criteria NCCN Appropriate Use Criteria ·NCCN guidelines, AU Criteria, AJCC TNM classification, PERCIST criteria oriented 18F-FDG Metabolic iTNM Scintigraphy - Synoptic Report Templates ·Metabolic iTNM Scintigraphy ·Patient Pathway and Public Education

𝐈𝐧𝐝𝐮𝐜𝐢𝐧𝐠 𝐈𝐦𝐦𝐮𝐧𝐨𝐠𝐞𝐧𝐢𝐜 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐞𝐥𝐥 𝐃𝐞𝐚𝐭𝐡 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐍𝐨𝐯𝐞𝐥 𝐏𝐡𝐨𝐭𝐨𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 Cancer treatment has long been a challenging field, with researchers continuously seeking innovative methods to enhance therapeutic outcomes. Recently, a significant breakthrough has been made by a multidisciplinary team led by Professors Gigi P.-C. Lo and Kwan T. Chow from the Department of Biomedical Sciences at City University of Hong Kong. Their pioneering research, titled “Inducing Immunogenic Cancer Cell Death through Oxygen-Economized Photodynamic Therapy with Nitric Oxide-Releasing Photosensitizers,” has been published in Angewandte Chemie International Edition (with Impact Factor of 16.6; 2022 Journal Citation Reports, Clarivate, 2023). #CancerResearch #CancerTreatment #ImmunotherapyBreakthrough #PhotodynamicTherapy #NitricOxidePhotosensitizers #BiomedicalInnovation Link: https://lnkd.in/gjJciy_h

Bowel Research UK is supporting vital research aimed at understanding how acidity levels within tumours influence treatment responses in cancer patients. This study, led by Professor Pawel Swietach at the University of Oxford, investigates the role of tumour acidity in affecting drug resistance and the release of proteins that can aid in diagnosis. By identifying new markers related to acidity, the research team hopes to provide insights that could personalise treatment for patients, ultimately improving their care and outcomes. For more details on this project, visit: https://lnkd.in/eXfM4F-9 #BowelResearch #CancerResearch #TumourAcidity #PatientCare #Research #BowelCancer

Join an inspiring session on Wednesday, May 8th, 2024, at 5 PM CET with academic key opinion leaders as they are sharing insight about #NMR-based* #metabolomics combined with insights into lipoproteins and their subclasses in disease research: https://lnkd.in/d-a_W-tp Prof Tone Bathen and Dr. Christoph Trautwein will present findings from their studies in infectious diseases and cancer research, highlighting key insights into the analytical process aimed at identifying prognostic and predictive biomarkers. *Research use only. Bruker NMR instruments are not intended for use in clinical diagnostic procedures.